Loading…
Multiple focal nodular hyperplasia: MRI features
To describe MRI features of multiple Focal Nodular Hyperplasia (FNHs). 40 consecutive subjects (37 females, mean age, 38.8years) were included. All studies were independently reviewed. This was an observational study to define the radiological features of multifocal FNH. 130 lesions were evaluated....
Saved in:
Published in: | Clinical imaging 2018-05, Vol.49, p.89-96 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c396t-b2852ae9659fba6834288a9b2acd812cda35dfe704cd36e18ad8eb5025bf73a43 |
---|---|
cites | cdi_FETCH-LOGICAL-c396t-b2852ae9659fba6834288a9b2acd812cda35dfe704cd36e18ad8eb5025bf73a43 |
container_end_page | 96 |
container_issue | |
container_start_page | 89 |
container_title | Clinical imaging |
container_volume | 49 |
creator | Busireddy, Kiran K. Ramalho, Miguel AlObaidy, Mamdoh Matos, António P. Burke, Lauren M. Dale, Brian M. Semelka, Richard C. |
description | To describe MRI features of multiple Focal Nodular Hyperplasia (FNHs).
40 consecutive subjects (37 females, mean age, 38.8years) were included. All studies were independently reviewed. This was an observational study to define the radiological features of multifocal FNH.
130 lesions were evaluated. The majority (88.5%), were peripheral in location. 92.3% lesions were lobulated. Marked enhancement was present in 94.6% lesions. In the portal venous and delayed phase, 46.2% and 47.7% lesions were mildly hyperintense. Central scar was present in 77% lesions.
Distinctive features included predominant subcapsular location and mild hyperintensity in the delayed phase, seen in nearly 50% of FNHs.
•This is the first series description of multiple FNHs by MRI.•The appearance of FNHs in the setting of multiple FNHs is comparable to that of solitary FNHs.•The majority of lesions were subcapsular in location.•Mild hyperintensity was seen in the interstitial phase in near 50% of the lesions.•Fatty FNHs were not uncommon and were seen in 11.5% of lesions. |
doi_str_mv | 10.1016/j.clinimag.2017.11.010 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1971639224</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0899707117302413</els_id><sourcerecordid>2037416877</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-b2852ae9659fba6834288a9b2acd812cda35dfe704cd36e18ad8eb5025bf73a43</originalsourceid><addsrcrecordid>eNqFkE1P3DAURS1EBQPtXxhFYsMmqZ-dxDYrECofEqhSBWvLsV_AI0-S2gnS_PtmNDNdsGH1Nufe-3QIWQItgEL9c1XY4Du_Nm8FoyAKgIICPSILkILnZanUMVlQqVQuqIBTcpbSis5BVYoTcsoUKFqBXBD6PIXRDwGztrcmZF3vpmBi9r4ZMA7BJG-usuc_j1mLZpwipu_kW2tCwh_7e05e73693D7kT7_vH29vnnLLVT3mDZMVM6jqSrWNqSUvmZRGNcxYJ4FZZ3jlWhS0tI7XCNI4iU1FWdW0gpuSn5PLXe8Q-78TplGvfbIYgumwn5IGJaDmirEtevEJXfVT7ObvNKNclFBLIWaq3lE29ilFbPUQZ39xo4HqrVO90geneutUA-jZ6Rxc7uunZo3uf-wgcQaudwDOPj48Rp2sx86i8xHtqF3vv9r4B4aKidE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2037416877</pqid></control><display><type>article</type><title>Multiple focal nodular hyperplasia: MRI features</title><source>ScienceDirect Freedom Collection</source><creator>Busireddy, Kiran K. ; Ramalho, Miguel ; AlObaidy, Mamdoh ; Matos, António P. ; Burke, Lauren M. ; Dale, Brian M. ; Semelka, Richard C.</creator><creatorcontrib>Busireddy, Kiran K. ; Ramalho, Miguel ; AlObaidy, Mamdoh ; Matos, António P. ; Burke, Lauren M. ; Dale, Brian M. ; Semelka, Richard C.</creatorcontrib><description>To describe MRI features of multiple Focal Nodular Hyperplasia (FNHs).
40 consecutive subjects (37 females, mean age, 38.8years) were included. All studies were independently reviewed. This was an observational study to define the radiological features of multifocal FNH.
130 lesions were evaluated. The majority (88.5%), were peripheral in location. 92.3% lesions were lobulated. Marked enhancement was present in 94.6% lesions. In the portal venous and delayed phase, 46.2% and 47.7% lesions were mildly hyperintense. Central scar was present in 77% lesions.
Distinctive features included predominant subcapsular location and mild hyperintensity in the delayed phase, seen in nearly 50% of FNHs.
•This is the first series description of multiple FNHs by MRI.•The appearance of FNHs in the setting of multiple FNHs is comparable to that of solitary FNHs.•The majority of lesions were subcapsular in location.•Mild hyperintensity was seen in the interstitial phase in near 50% of the lesions.•Fatty FNHs were not uncommon and were seen in 11.5% of lesions.</description><identifier>ISSN: 0899-7071</identifier><identifier>EISSN: 1873-4499</identifier><identifier>DOI: 10.1016/j.clinimag.2017.11.010</identifier><identifier>PMID: 29190518</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Abdomen ; Adolescent ; Adult ; Aged ; Confidence intervals ; Contrast agents ; Contrast Media ; FDA approval ; Female ; Females ; FNH ; Focal Nodular Hyperplasia - diagnostic imaging ; Gangrene ; Hepatobiliary contrast agents ; Humans ; Hyperplasia ; Lesions ; Liver ; Liver - diagnostic imaging ; Magnetic Resonance Imaging ; Male ; Middle Aged ; MRI ; Multiple nodular focal hyperplasias ; NMR ; Nuclear magnetic resonance ; Portal Vein - diagnostic imaging ; Retrospective Studies ; Studies ; Telangiectatic ; Tumors ; Young Adult</subject><ispartof>Clinical imaging, 2018-05, Vol.49, p.89-96</ispartof><rights>2017</rights><rights>Copyright © 2017. Published by Elsevier Inc.</rights><rights>Copyright Elsevier Limited May 2018</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-b2852ae9659fba6834288a9b2acd812cda35dfe704cd36e18ad8eb5025bf73a43</citedby><cites>FETCH-LOGICAL-c396t-b2852ae9659fba6834288a9b2acd812cda35dfe704cd36e18ad8eb5025bf73a43</cites><orcidid>0000-0002-9081-0087</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29190518$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Busireddy, Kiran K.</creatorcontrib><creatorcontrib>Ramalho, Miguel</creatorcontrib><creatorcontrib>AlObaidy, Mamdoh</creatorcontrib><creatorcontrib>Matos, António P.</creatorcontrib><creatorcontrib>Burke, Lauren M.</creatorcontrib><creatorcontrib>Dale, Brian M.</creatorcontrib><creatorcontrib>Semelka, Richard C.</creatorcontrib><title>Multiple focal nodular hyperplasia: MRI features</title><title>Clinical imaging</title><addtitle>Clin Imaging</addtitle><description>To describe MRI features of multiple Focal Nodular Hyperplasia (FNHs).
40 consecutive subjects (37 females, mean age, 38.8years) were included. All studies were independently reviewed. This was an observational study to define the radiological features of multifocal FNH.
130 lesions were evaluated. The majority (88.5%), were peripheral in location. 92.3% lesions were lobulated. Marked enhancement was present in 94.6% lesions. In the portal venous and delayed phase, 46.2% and 47.7% lesions were mildly hyperintense. Central scar was present in 77% lesions.
Distinctive features included predominant subcapsular location and mild hyperintensity in the delayed phase, seen in nearly 50% of FNHs.
•This is the first series description of multiple FNHs by MRI.•The appearance of FNHs in the setting of multiple FNHs is comparable to that of solitary FNHs.•The majority of lesions were subcapsular in location.•Mild hyperintensity was seen in the interstitial phase in near 50% of the lesions.•Fatty FNHs were not uncommon and were seen in 11.5% of lesions.</description><subject>Abdomen</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Confidence intervals</subject><subject>Contrast agents</subject><subject>Contrast Media</subject><subject>FDA approval</subject><subject>Female</subject><subject>Females</subject><subject>FNH</subject><subject>Focal Nodular Hyperplasia - diagnostic imaging</subject><subject>Gangrene</subject><subject>Hepatobiliary contrast agents</subject><subject>Humans</subject><subject>Hyperplasia</subject><subject>Lesions</subject><subject>Liver</subject><subject>Liver - diagnostic imaging</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Middle Aged</subject><subject>MRI</subject><subject>Multiple nodular focal hyperplasias</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Portal Vein - diagnostic imaging</subject><subject>Retrospective Studies</subject><subject>Studies</subject><subject>Telangiectatic</subject><subject>Tumors</subject><subject>Young Adult</subject><issn>0899-7071</issn><issn>1873-4499</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNqFkE1P3DAURS1EBQPtXxhFYsMmqZ-dxDYrECofEqhSBWvLsV_AI0-S2gnS_PtmNDNdsGH1Nufe-3QIWQItgEL9c1XY4Du_Nm8FoyAKgIICPSILkILnZanUMVlQqVQuqIBTcpbSis5BVYoTcsoUKFqBXBD6PIXRDwGztrcmZF3vpmBi9r4ZMA7BJG-usuc_j1mLZpwipu_kW2tCwh_7e05e73693D7kT7_vH29vnnLLVT3mDZMVM6jqSrWNqSUvmZRGNcxYJ4FZZ3jlWhS0tI7XCNI4iU1FWdW0gpuSn5PLXe8Q-78TplGvfbIYgumwn5IGJaDmirEtevEJXfVT7ObvNKNclFBLIWaq3lE29ilFbPUQZ39xo4HqrVO90geneutUA-jZ6Rxc7uunZo3uf-wgcQaudwDOPj48Rp2sx86i8xHtqF3vv9r4B4aKidE</recordid><startdate>201805</startdate><enddate>201805</enddate><creator>Busireddy, Kiran K.</creator><creator>Ramalho, Miguel</creator><creator>AlObaidy, Mamdoh</creator><creator>Matos, António P.</creator><creator>Burke, Lauren M.</creator><creator>Dale, Brian M.</creator><creator>Semelka, Richard C.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>M7Z</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9081-0087</orcidid></search><sort><creationdate>201805</creationdate><title>Multiple focal nodular hyperplasia: MRI features</title><author>Busireddy, Kiran K. ; Ramalho, Miguel ; AlObaidy, Mamdoh ; Matos, António P. ; Burke, Lauren M. ; Dale, Brian M. ; Semelka, Richard C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-b2852ae9659fba6834288a9b2acd812cda35dfe704cd36e18ad8eb5025bf73a43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Abdomen</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Confidence intervals</topic><topic>Contrast agents</topic><topic>Contrast Media</topic><topic>FDA approval</topic><topic>Female</topic><topic>Females</topic><topic>FNH</topic><topic>Focal Nodular Hyperplasia - diagnostic imaging</topic><topic>Gangrene</topic><topic>Hepatobiliary contrast agents</topic><topic>Humans</topic><topic>Hyperplasia</topic><topic>Lesions</topic><topic>Liver</topic><topic>Liver - diagnostic imaging</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Middle Aged</topic><topic>MRI</topic><topic>Multiple nodular focal hyperplasias</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Portal Vein - diagnostic imaging</topic><topic>Retrospective Studies</topic><topic>Studies</topic><topic>Telangiectatic</topic><topic>Tumors</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Busireddy, Kiran K.</creatorcontrib><creatorcontrib>Ramalho, Miguel</creatorcontrib><creatorcontrib>AlObaidy, Mamdoh</creatorcontrib><creatorcontrib>Matos, António P.</creatorcontrib><creatorcontrib>Burke, Lauren M.</creatorcontrib><creatorcontrib>Dale, Brian M.</creatorcontrib><creatorcontrib>Semelka, Richard C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical imaging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Busireddy, Kiran K.</au><au>Ramalho, Miguel</au><au>AlObaidy, Mamdoh</au><au>Matos, António P.</au><au>Burke, Lauren M.</au><au>Dale, Brian M.</au><au>Semelka, Richard C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multiple focal nodular hyperplasia: MRI features</atitle><jtitle>Clinical imaging</jtitle><addtitle>Clin Imaging</addtitle><date>2018-05</date><risdate>2018</risdate><volume>49</volume><spage>89</spage><epage>96</epage><pages>89-96</pages><issn>0899-7071</issn><eissn>1873-4499</eissn><abstract>To describe MRI features of multiple Focal Nodular Hyperplasia (FNHs).
40 consecutive subjects (37 females, mean age, 38.8years) were included. All studies were independently reviewed. This was an observational study to define the radiological features of multifocal FNH.
130 lesions were evaluated. The majority (88.5%), were peripheral in location. 92.3% lesions were lobulated. Marked enhancement was present in 94.6% lesions. In the portal venous and delayed phase, 46.2% and 47.7% lesions were mildly hyperintense. Central scar was present in 77% lesions.
Distinctive features included predominant subcapsular location and mild hyperintensity in the delayed phase, seen in nearly 50% of FNHs.
•This is the first series description of multiple FNHs by MRI.•The appearance of FNHs in the setting of multiple FNHs is comparable to that of solitary FNHs.•The majority of lesions were subcapsular in location.•Mild hyperintensity was seen in the interstitial phase in near 50% of the lesions.•Fatty FNHs were not uncommon and were seen in 11.5% of lesions.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>29190518</pmid><doi>10.1016/j.clinimag.2017.11.010</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-9081-0087</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0899-7071 |
ispartof | Clinical imaging, 2018-05, Vol.49, p.89-96 |
issn | 0899-7071 1873-4499 |
language | eng |
recordid | cdi_proquest_miscellaneous_1971639224 |
source | ScienceDirect Freedom Collection |
subjects | Abdomen Adolescent Adult Aged Confidence intervals Contrast agents Contrast Media FDA approval Female Females FNH Focal Nodular Hyperplasia - diagnostic imaging Gangrene Hepatobiliary contrast agents Humans Hyperplasia Lesions Liver Liver - diagnostic imaging Magnetic Resonance Imaging Male Middle Aged MRI Multiple nodular focal hyperplasias NMR Nuclear magnetic resonance Portal Vein - diagnostic imaging Retrospective Studies Studies Telangiectatic Tumors Young Adult |
title | Multiple focal nodular hyperplasia: MRI features |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T03%3A09%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multiple%20focal%20nodular%20hyperplasia:%20MRI%20features&rft.jtitle=Clinical%20imaging&rft.au=Busireddy,%20Kiran%20K.&rft.date=2018-05&rft.volume=49&rft.spage=89&rft.epage=96&rft.pages=89-96&rft.issn=0899-7071&rft.eissn=1873-4499&rft_id=info:doi/10.1016/j.clinimag.2017.11.010&rft_dat=%3Cproquest_cross%3E2037416877%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c396t-b2852ae9659fba6834288a9b2acd812cda35dfe704cd36e18ad8eb5025bf73a43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2037416877&rft_id=info:pmid/29190518&rfr_iscdi=true |